Status:
UNKNOWN
Natural Course and Prognosis of Hospitalized Patients With Cirrhosis
Lead Sponsor:
Kangbuk Samsung Hospital
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
20+ years
Brief Summary
The aim of this prospective study is to evaluate the natural course and prognosis of hospitalized patients with liver cirrhosis.
Detailed Description
The aim of this prospective study is to collect data on hospitalized patients with liver cirrhosis at four institutions in Korea (Kangbuk Samsung Hospital, Hallym University Dongtan Sacred Heart Hospi...
Eligibility Criteria
Inclusion
- Hospitalized patients with liver cirrhosis
- Admission to the hospital because of cirrhotic complications such as uncontrolled ascites, variceal bleeding, hepatic encephalopathy, hepatorenal syndrome, spontaneous bacterial peritonitis, hepatocellular carcinoma, acute kidney injury, bacterial infection, acute liver failure, and etc.
Exclusion
- Admission to the hospital without cirrhotic complications
- Patients who refuse the follow-up of outpatient department
Key Trial Info
Start Date :
November 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 31 2025
Estimated Enrollment :
336 Patients enrolled
Trial Details
Trial ID
NCT05185154
Start Date
November 1 2021
End Date
October 31 2025
Last Update
January 11 2022
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Hallym University Dongtan Sacred Heart Hospital
Hwaseong-si, South Korea
2
Chosun University Hospital
Kwangju, South Korea
3
Jae Yoon Jeong
Seoul, South Korea
4
Kangbuk Samsung Hospital
Seoul, South Korea